Concord Health Partners
25 Deforest Avenue, Suite 108, Summit, NJ, 07901, United States
Overview
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Thyme Care | Sep 2026Participated | $125 MSeries E | |
Scan.com | Aug 2026Participated | $220 MDebt | |
Thyme Care | Sep 2025Participated | $97 MSeries D | |
Pieces | Sep 2024Participated | $25 MOther Equity | |
Loyal | Jul 2024Led | $34 MSeries B | |
Thyme Care | Jul 2024Led | $95 MSeries C | |
Accelus | Jul 2022Led | $12 MSeries D | |
Iris Telehealth | Apr 2022Led | $40 MSeries B | |
MindMaze | Feb 2022Led | $105 MOther Equity | |
Cylera | Mar 2021Led | $10 MSeries A | |
Clarify Health Solutions | Mar 2021Led | $115 MSeries C | |
Cedar | Mar 2021Participated | $200 MSeries D | |
Thyme Care | Sep 2026Participated | $125 MSeries E | |
Scan.com | Aug 2026Participated | $220 MDebt | |
Thyme Care | Sep 2025Participated | $97 MSeries D | |
Pieces | Sep 2024Participated | $25 MOther Equity | |
Loyal | Jul 2024Led | $34 MSeries B | |
Thyme Care | Jul 2024Led | $95 MSeries C | |
Accelus | Jul 2022Led | $12 MSeries D | |
Iris Telehealth | Apr 2022Led | $40 MSeries B | |
MindMaze | Feb 2022Led | $105 MOther Equity | |
Cylera | Mar 2021Led | $10 MSeries A | |
Clarify Health Solutions | Mar 2021Led | $115 MSeries C | |
Cedar | Mar 2021Participated | $200 MSeries D |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 3 | 0 |
| Series B | 3 | 1 |
| Series C+ | 4 | 3 |
| Other Equity | 1 | 1 |
| Debt | 0 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Sep '19 | 1 |
| Oct '19 | 0 |
| Nov '19 | 1 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 1 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 1 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 1 |
| Feb '21 | 0 |
| Mar '21 | 3 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 1 |
| Mar '22 | 0 |
| Apr '22 | 1 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 1 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 2 |
| Aug '24 | 0 |
| Sep '24 | 1 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 1 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 1 |
| Sep '26 | 1 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 16 |
| AI & Machine Learning | 7 |
| Data, Analytics & IT | 6 |
| Networks, Cloud & Communication | 2 |
| Enterprise Software | 2 |
| Fintech | 2 |
| Cybersecurity & Privacy | 2 |
| Space & Frontier Tech | 2 |
| Hardware & Robotics | 1 |
| E-Commerce & Retail | 1 |
| AR/VR | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 0 |
| $10M-$25M | 6 |
| $25M-$50M | 4 |
| $50M-$100M | 2 |
| $100M-$250M | 5 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 15 |
| Europe | 2 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| AlleyCorp | 3 |
| Andreessen Horowitz | 3 |
| CVS Health Ventures | 3 |
| Foresite Capital | 3 |
| Frist Cressey Ventures | 3 |
| Town Hall Ventures | 3 |
| Humana | 2 |
| J.P. Morgan | 2 |
| AlbaCore Capital Group | 1 |
| Aphelion | 1 |
| Aphelion/Cardeation Capital | 1 |
| Atempo Growth | 1 |
| Aviva Ventures | 1 |
| B Capital Group | 1 |
| Children's Health | 1 |
| Columbia Pacific Advisors | 1 |
| Contour Venture Partners | 1 |
| Deerfield Management | 1 |
| Dreamit Ventures | 1 |
| Echo Health Ventures | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 11 | 65% |
| Participating | 6 | 35% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 7 | 64% |
| Co-led | 4 | 36% |
Team
COO/CFO
Executive Partner
Founder & Managing Partner
Co-Founder & Partner
Managing Director